LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H Statistics
Want to see HK:2291 full AI Analyst Report?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (2291) Stock Statistics & Valuation Metrics
Total Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has a market cap or net worth of HKD 4.72B. The enterprise value is HKD 2.04B.
- Market Cap
- HKD 4.72B
- Enterprise Value
- HKD 2.04B
Share Statistics
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 341,776,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 341,776,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.21%
Financial Efficiency
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.75%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 11.75%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 1.42M
- Profits Per Employee
- 646.17K
- Employee Count
- 371
- Asset Turnover
- 0.25
- Inventory Turnover
- 0.73
Valuation Ratios
The current PE Ratio of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is 19.47. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s PEG ratio is -0.69.
- PE Ratio
- 19.47
- PS Ratio
- 7.77
- PB Ratio
- 1.99
- Price to FCF
- 25.02
- Price to Operating Cash Flow
- 19.09
- PEG Ratio
- -0.69
Income Statement
In the last 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H had revenue of 527.94M and earned 239.73M in profits. Earnings per share was 0.69.
- Revenue
- 527.94M
- Gross Profit
- 446.95M
- Operating Income
- 276.54M
- Pretax Income
- 276.46M
- Net Income
- 239.73M
- EBITDA
- 286.23M
- Earnings Per Share (EPS)
- 0.69
Cash Flow
In the last 12 months, operating cash flow was 208.56M and capital expenditures -51.97M, giving a free cash flow of 156.58M billion.
- Operating Cash Flow
- 208.56M
- Free Cash Flow
- 156.58M
- Free Cash Flow per Share
- 0.45
Dividends & Yields
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pays an annual dividend of HKD 0.57, resulting in a dividend yield of 4.14%
- Dividend Per Share
- HKD 0.57
- Dividend Yield
- 4.14%
- Payout Ratio
- 72.43%
- Free Cash Flow Yield
- 4.00%
- Earnings Yield
- 5.08%
Stock Price Statistics
- Beta
- 0.75
- 52-Week Price Change
- -26.65%
- 50-Day Moving Average
- 12.91
- 200-Day Moving Average
- 12.37
- Relative Strength Index (RSI)
- 49.72
- Average Volume (3m)
- 663.87K
Important Dates
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Mar 26, 2027
- Ex-Dividend Date
- May 27, 2026
Financial Position
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H as a current ratio of 23.54, with Debt / Equity ratio of 0.08%
- Current Ratio
- 23.54
- Quick Ratio
- 21.71
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -4.04
- Interest Coverage Ratio
- 2370.99
Taxes
In the past 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has paid 36.74M in taxes.
- Income Tax
- 36.74M
- Effective Tax Rate
- 0.13
Enterprise Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H EV to EBITDA ratio is 10.62, with an EV/FCF ratio of 17.12.
- EV to Sales
- 5.32
- EV to EBITDA
- 10.62
- EV to Free Cash Flow
- 17.12
- EV to Operating Cash Flow
- 12.85
Balance Sheet
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has HKD 1.29B in cash and marketable securities with HKD 1.40M in debt, giving a net cash position of HKD 1.29B billion.
- Cash & Marketable Securities
- HKD 1.29B
- Total Debt
- HKD 1.40M
- Net Cash
- HKD 1.29B
- Net Cash Per Share
- HKD 3.76
- Tangible Book Value Per Share
- HKD 4.44
Margins
Gross margin is 82.04%, with operating margin of 44.71%, and net profit margin of 40.12%.
- Gross Margin
- 82.04%
- Operating Margin
- 44.71%
- Pretax Margin
- 46.35%
- Net Profit Margin
- 40.12%
- EBITDA Margin
- 50.07%
- EBIT Margin
- 43.28%
Analyst Forecast
The average price target for LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.20%
- EPS Growth Forecast
- -25.57%
Scores
- Smart Score
- 6
- AI Score
- 85

